Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000061

Principal Accounting Officer sold 250 shares at $39.93 ($9,983)

From the SEC's structured data for this filing

Trades in this filing

Alenson Carman · Principal Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-02 Sale : show line 1 in the form −250 $39.93 $9,983 184 D
Open-market sales · 250 sh · avg $39.93 · $9,983
Loading xslF345X03/wf-form4_159925103182387.xml…